-
-
Call more information
660-596-2224 -
The use of sumatriptan decreases post-operative headache at the non-surgical site in patients who undergo craniotomy for the treatment of trigeminal neuralgia and facial spasms, researchers said here at the 2015 Annual Meeting of the Canadian Anesthesiologists’ Society (CAS). “These patients complain of pain at the non-surgical site as well as nausea and vomiting,” said […]
Read MorePatients who minimally used opioids prior to surgery, but who continued to use them for pain relief 30 days after surgery were likely to be using them in the longer term, according to a study presented here at the 2015 Annual Meeting of the Canadian Anesthesiologists’ Society (CAS). With ongoing opioid use being a public […]
Read MoreSumatriptan is less effective in migraine attacks with aura than in those without, new data reveal. The findings, from an analysis of previous clinical trial results, were presented here at the American Headache Society (AHS) 57th Annual Scientific Meeting by Jakob Møller Hansen, MD, PhD, a resident at the Department of Neurology at Rigshospitalet and […]
Read MoreFentanyl 50 and 100 mcg is useful in accelerating the onset of labour analgesia without compromising safety, according to a study presented here at the 2015 Annual Meeting of the Canadian Anesthesiologists’ Society (CAS). “We have been decreasing our concentrations of our local anaesthetics, and we find that one of the impacts of that is […]
Read MoreThe use of periarticular ketorolac, an anti-platelet agent, does not produce additional blood loss in patients undergoing total knee arthroplasty (TKA), a retrospective study presented here at the annual meeting of the Canadian Anesthesiologists’ Society concludes. The study compared 57 patients who received periarticular ketorolac injection and 33 patients who didn’t (controls). Because ketorolac is […]
Read More